Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;9(5):709-20.
doi: 10.1007/s12015-013-9452-5.

Suppression of malignancy by Smad3 in mouse embryonic stem cell formed teratoma

Affiliations

Suppression of malignancy by Smad3 in mouse embryonic stem cell formed teratoma

Peng Li et al. Stem Cell Rev Rep. 2013 Oct.

Erratum in

  • Stem Cell Rev. 2013 Dec;9(6):874. Xiaoming, Meng [corrected to Meng, Xiaoming]

Abstract

Disease associated gene deficient embryonic stem cells can serve as valuable in vitro models to study disease mechanisms and screen drugs. Smad3 mediated TGF-β/Activin/Nodal signaling plays important roles in many biological processes. Despite numerous studies regarding Smad3 function, the role of Smad3 in mouse ES cells is not well studied. To understand the function of Smad3 in mouse ES cells, we derived Smad3-/- ES cells and wild type ES cells. Smad3-/- ES cells display no defect on self-renewal. They express similar level of pluripotent genes and lineage genes compared to wild type ES cells. However, Smad3 ablation results in transient difference in germ layer marker expression during embryoid body formation. Mesoderm lineage marker expression is significantly reduced in the embryoid body formed by Smad3-/- ES cells compared to wild type ES cells. Intriguingly, subcutaneous injection of Smad3-/- ES cells into nude mice leads to formation of malignant immature teratomas, whilst wild type ES cells tend to form mature teratomas. Smad3-/- ES cell formed teratomas can therefore provide a new model for the study of the mechanism of malignant teratomas.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Stem Cells. 2001;19(6):477-82 - PubMed
    1. Genes Dev. 2005 Dec 1;19(23):2783-810 - PubMed
    1. Cell Stem Cell. 2008 Aug 7;3(2):127-8 - PubMed
    1. Nat Biotechnol. 2009 Mar;27(3):281-7 - PubMed
    1. J Histochem Cytochem. 1995 Jan;43(1):97-102 - PubMed

MeSH terms

LinkOut - more resources